Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sarcoma of the uterus]

T Fait1, P Freitag, J Zivný

  • 1II. gynek.-porod, klinika 1. LF UK a VFN, Praha.

Ceska Gynekologie
|September 29, 1998
PubMed
Summary

This study on uterine sarcoma in 39 patients found a 36% 5-year survival rate. Abdominal hysterectomy is recommended as primary treatment for uterine sarcoma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patients' Symptoms and Support Needs at Start of Specialized Palliative Care Therapy in an Inpatient Oncology Setting. A Retrospective Data Analysis.

The American journal of hospice & palliative care·2026
Same author

The role of connexin 37 polymorphism in spontaneous abortion.

Physiological research·2021
Same author

DT56a in treatment of climacteric syndrome in the Central European population sample.

Bratislavske lekarske listy·2021
Same author

Prenatally diagnosed patent urachus with umbilical cord cyst and early surgical intervention.

Ceska gynekologie·2020
Same author

Sacrococcygeal teratoma.

Ceska gynekologie·2019
Same author

Advance maternal age - risk factor for low birhtweight.

Ceska gynekologie·2019

Area of Science:

  • Gynecologic Oncology
  • Surgical Oncology
  • Clinical Research

Context:

  • Uterine sarcoma is a rare and aggressive malignancy.
  • Optimal treatment strategies require further investigation.
  • Retrospective clinical studies provide valuable insights into patient outcomes.

Purpose:

  • To present clinical experience with uterine sarcoma treatment.
  • To evaluate the efficacy of primary surgical intervention.
  • To discuss the role of adjuvant therapies based on histological subtypes.

Summary:

  • A retrospective study included 39 uterine sarcoma patients (average age 58).
  • Overall 5-year survival was 36%.
  • Abdominal hysterectomy, with or without bilateral salpingo-oophorectomy, is recommended as primary therapy.

Impact:

  • Highlights the importance of timely surgical intervention for uterine sarcoma.
  • Emphasizes the need for tailored adjuvant treatment strategies (radiotherapy, chemotherapy).
  • Contributes to understanding prognostic factors in uterine sarcoma management.

Related Experiment Videos